Insulin Resistance in Your 20s and 30s

✓ Medically reviewed | Published: | Evidence level: 1A
A CARDIA cohort analysis reported by MedPage Today found that insulin resistance measured in young adulthood predicted atherosclerotic cardiovascular disease (ASCVD) years later in middle age. The finding suggests metabolic risk may begin building long before diabetes or heart disease is diagnosed, and strengthens the case for earlier screening and lifestyle intervention.
📅 Published:
✓ Reviewed by iMedic Medical Editorial Team
📄 Cardiovascular Health

Quick Facts

Cohort
CARDIA, long-running US study
Key finding
Early insulin resistance predicts ASCVD
Window
Young adulthood to middle age
Modifiable?
Largely, via lifestyle

Can insulin resistance in young adulthood predict heart disease later in life?

Quick answer: Yes, according to a CARDIA cohort analysis, insulin resistance around age 30 was associated with a higher likelihood of atherosclerotic cardiovascular disease in middle age.

The Coronary Artery Risk Development in Young Adults (CARDIA) study is a long-running US cohort that has followed Black and white adults since they were young, tracking cardiovascular risk factors over decades. An analysis summarized by MedPage Today reports that insulin resistance measured in young adulthood was a predictor of atherosclerotic cardiovascular disease (ASCVD) years later. The finding fits a broader picture in which metabolic dysfunction accumulates silently for years before clinical disease appears.

Insulin resistance means that muscle, liver and fat tissue respond less effectively to insulin, so the pancreas compensates by producing more of it. Chronically elevated insulin and the metabolic changes that accompany it, including raised triglycerides, lower HDL cholesterol, higher blood pressure and abdominal fat accumulation, promote endothelial dysfunction, inflammation and plaque formation in arteries. Because these processes unfold over decades, exposure in early adulthood may matter more than a single measurement in midlife suggests.

Why does early metabolic health matter for long-term cardiovascular risk?

Quick answer: Cardiovascular damage accumulates over time, so metabolic abnormalities in young adults may contribute to cumulative arterial injury long before symptoms or standard diagnoses emerge.

Most cardiovascular risk assessment tools focus on adults in their 40s and older and are designed to estimate 10-year risk, which is often low in younger people even when underlying metabolic problems are present. Findings like those from CARDIA argue for a life-course view: a young adult with normal-looking fasting glucose may still have meaningful insulin resistance, and that hidden state may carry prognostic information. Rising rates of obesity among younger people make this especially relevant to public health.

The encouraging aspect is that insulin resistance is highly modifiable. Regular physical activity, including both aerobic and resistance training, reduction of excess visceral fat, adequate sleep, a diet rich in fiber, vegetables and minimally processed foods, and avoidance of smoking all improve insulin sensitivity. Clinicians may consider risk-enhancing factors such as family history of diabetes, gestational diabetes, polycystic ovary syndrome, and features of metabolic syndrome when deciding whom to evaluate earlier. Observational findings show association rather than proof of causation, and individual risk depends on many factors.

What can young adults do to lower their risk?

Quick answer: Building lifelong habits such as regular exercise, a healthy diet, weight management and routine check-ups can improve insulin sensitivity and reduce future cardiovascular risk.

Public health guidance, including recommendations from the American Heart Association and the World Health Organization, emphasizes at least 150 minutes of moderate-intensity physical activity per week for adults, alongside muscle-strengthening activity. Even modest weight loss in people with excess weight can meaningfully improve insulin sensitivity, blood pressure and lipid profiles. Limiting sugar-sweetened beverages and ultra-processed foods, and prioritizing sleep, supports metabolic health.

Routine primary care visits that include blood pressure, lipid, and glucose or HbA1c testing can identify early warning signs. People with a family history of type 2 diabetes or heart disease, or with conditions linked to insulin resistance, may wish to discuss earlier or more frequent screening with their clinician. The key message from this research is that prevention does not need to wait for midlife.

Frequently Asked Questions

Insulin resistance is a condition in which the body's cells respond poorly to insulin, prompting the pancreas to produce more of it to keep blood sugar in range. It often precedes type 2 diabetes and is associated with higher cardiovascular risk.

In many people it can be substantially improved through regular physical activity, weight loss when appropriate, a healthy diet, better sleep and, in some cases, medication prescribed by a clinician.

No. Cohort analyses show an association and a predictive relationship, but they cannot prove causation. Other overlapping factors such as obesity, blood pressure and lipids also contribute.

Routine testing is not universally recommended, but people with risk factors such as obesity, family history of diabetes, or polycystic ovary syndrome may benefit from discussing glucose and lipid screening with their doctor.

References

  1. MedPage Today. Insulin Resistance by Age 30 Quite Telling of Future Heart Health. CARDIA cohort analysis. 2026.
  2. American Heart Association. Physical activity recommendations for adults.
  3. World Health Organization. Global recommendations on physical activity for health.